Status:
COMPLETED
Insulin Pump-RT Advisor (IPRA©): a Decision Support Software for Diabetic Patients Treated by Insulin Pump and Using Continuous Glucose Monitoring. Experimental Study. Evaluation by an Expert Patient Panel.
Lead Sponsor:
Rennes University Hospital
Conditions:
Type 1 Diabetes
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The purpose of the study is to assess the relevance of the advices provided by the IPRA© smartphone application for guiding the responses of insulin pump treated type 1 diabetes patients using real-ti...
Detailed Description
Patients will be asked to evaluate the IPRA advices by connecting to IPRA© application by using their smartphone, 30 times a week for two weeks. At the end of this two week period, a satisfaction ques...
Eligibility Criteria
Inclusion
- men and women ≥ 18 years of age,
- patients with type 1 diabetes for more than 2 years,
- patients treated by insulin pump for more than 6 months,
- patients using of real-time continuous glucose monitoring for more than 3 months,
- patients able to evaluate the IPRA advices by connecting to IPRA© application 30 times a week,
- patient able to provide written informed consent,
- patient able to provide written non-disclosure agreement
Exclusion
- pregnancy or breastfeeding,
- current infectious disease,
- patients with no smartphone® or Internet access,
- adults legally protected (under judicial protection, guardianship, or supervision), persons deprived of their liberty
Key Trial Info
Start Date :
June 1 2013
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 1 2013
Estimated Enrollment :
6 Patients enrolled
Trial Details
Trial ID
NCT01883024
Start Date
June 1 2013
End Date
September 1 2013
Last Update
May 24 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Service d'Endocrinologie-Diabétologie - CHU de Rennes - Hôpital Sud
Rennes, France, 35230